Why the study?
Do clinical outcomes differ between patients with hypokinetic non-dilated cardiomyopathy and classic dilated cardiomyopathy?
Do clinical outcomes differ between patients with hypokinetic non-dilated cardiomyopathy and classic dilated cardiomyopathy?
Patients with hypokinetic non-dilated cardiomyopathy have similar mortality risk to those with classic dilated cardiomyopathy, despite presenting with less severe symptoms and remodeling.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Dziewięcka et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: